Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular drugs.

P Vermeij1

  • 1Department of Clinical Pharmacy and Toxicology, University Hospital Leiden, The Netherlands.

Pharmaceutisch Weekblad. Scientific Edition
|August 21, 1992
PubMed
Summary

Future cardiovascular drug innovations include new thrombolytic therapies, improved antiarrhythmics, renin inhibitors for hypertension, and recombinant coagulation factors to address blood product shortages.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of the gastrointestinal effects of the nitrogen-containing bisphosphonates pamidronate, alendronate, and olpadronate in humans.

Journal of clinical pharmacology·2006
Same author

Adaptation of methane formation and enzyme contents during growth of Methanobacterium thermoautotrophicum (strain deltaH) in a fed-batch fermentor.

Antonie van Leeuwenhoek·2004
Same author

Pharmacokinetics of rectal tramadol in postoperative paediatric patients.

British journal of anaesthesia·2004
Same author

The sugar absorption test in the evaluation of the gastrointestinal intolerance to bisphosphonates: studies with oral pamidronate.

Clinical pharmacology and therapeutics·2001
Same author

The ssu locus plays a key role in organosulfur metabolism in Pseudomonas putida S-313.

Journal of bacteriology·2000
Same author

Semi-automatic liquid chromatographic analysis of olpadronate in urine and serum using derivatization with (9-fluorenylmethyl)chloroformate.

Journal of chromatography. B, Biomedical sciences and applications·2000

Area of Science:

  • Cardiovascular pharmacology and therapeutics.

Background:

  • Cardiovascular drugs encompass diverse pharmacotherapeutic groups.
  • Innovation is concentrated in specific high-impact areas.
  • Existing treatments face limitations, such as pro-arrhythmic effects and blood product shortages.

Purpose of the Study:

  • To provide an overview of likely future developments in cardiovascular pharmacotherapy.
  • To highlight emerging drug classes and technologies.

Main Methods:

  • Review of current trends and projected advancements in cardiovascular drug development.
  • Focus on areas with high potential for innovation.

Main Results:

  • Anticipated advancements in thrombolytic therapy, potentially yielding new primary drugs.
  • Continued development of novel class III anti-arrhythmics offering new therapeutic options.
  • Emergence of renin inhibitors as a new drug class for hypertension treatment.
  • Potential for new pharmacotherapeutic approaches from vascular pharmacology discoveries.
  • Recombinant technology to increase availability of coagulation factors, alleviating shortages.

Conclusions:

  • Significant innovations are expected across thrombolytic, antiarrhythmic, and antihypertensive therapies.
  • Recombinant coagulation factors promise to resolve blood product supply issues.
  • Future cardiovascular pharmacotherapy will benefit from targeted drug development and technological advancements.

Related Experiment Videos